Advances in technologies for cervical cancer detection in low-resource settings

Expert Review of Molecular Diagnostics
Kathryn A KundrodRebecca R Richards-Kortum

Abstract

Introduction: Cervical cancer mortality rates remain high in low- and middle-income countries (LMICs) and other medically underserved areas due to challenges with implementation and sustainability of routine screening, accurate diagnosis, and early treatment of preinvasive lesions. Areas covered: In this review, we first discuss the standard of care for cervical cancer screening and diagnosis in high- and low-resource settings, biomarkers that correlate to cervical precancer and cancer, and needs for new tests. We review technologies for screening and diagnosis with a focus on tests that are already in use in LMICs or have the potential to be adapted for use in LMICs. Finally, we provide perspectives on the next five years of technology development for improved cervical cancer screening and diagnosis in LMICs. Expert opinion: Innovation toward improved molecular and imaging tests is needed to enable effective, affordable see-and-treat approaches to detect and treat cervical precancer in a single visit. Current molecular tests remain too complex and/or costly for widespread use. Especially with imaging tests, decision support may improve performance of new technologies.

References

Dec 1, 1977·British Journal of Preventive & Social Medicine·M Hakama, E Pukkala
Aug 19, 1999·The Journal of Pathology·J M WalboomersN Muñoz
Mar 23, 2001·JAMA : the Journal of the American Medical Association·M H StolerUNKNOWN Atypical Squamous Cells of Undetermined Significance-Low-grade Squamous Intraepithelial Lesion Triage Study (ALTS) Group
Jan 31, 2003·British Journal of Cancer·G M CliffordS Franceschi
Apr 6, 2006·International Journal of Cancer. Journal International Du Cancer·Jack CuzickThomas Iftner
May 15, 2007·The New England Journal of Medicine·UNKNOWN FUTURE II Study Group
Oct 19, 2007·The New England Journal of Medicine·Marie-Hélène MayrandUNKNOWN Canadian Cervical Cancer Screening Trial Study Group
Dec 7, 2007·Obstetrics and Gynecology Clinics of North America·Mahboobeh SafaeianPhilip E Castle
Jun 27, 2008·Journal of Clinical Microbiology·Philip E CastleMark Schiffman
Apr 3, 2009·The New England Journal of Medicine·Rengaswamy SankaranarayananKetayun A Dinshaw
Jun 6, 2009·CytoJournal·Liron PantanowitzRobert A Goulart
Aug 11, 2009·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Damien JeantetAlain Troesch
Sep 29, 2009·BJOG : an International Journal of Obstetrics and Gynaecology·J TanW J McLaren
Dec 1, 2005·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Eun-Kyoung Yim, Jong-Sup Park
Dec 22, 2009·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Philippe HalfonBernard Blanc
Oct 12, 2010·Journal of Clinical Microbiology·Johannes SchweizerPhilip E Castle
Feb 24, 2011·The Journal of Infectious Diseases·Philip E CastleUNKNOWN Proyecto Epidemiológico Guanacaste Group
Mar 18, 2011·Lasers in Surgery and Medicine·Julia K S GallwasChristian Dannecker
Oct 1, 2011·Future Microbiology·Vikrant V SahasrabuddheNicolas Wentzensen
Apr 5, 2012·International Journal of Cancer. Journal International Du Cancer·Julia C GageMark Schiffman
Oct 25, 2012·Journal of the National Cancer Institute·Nicolas WentzensenRobert D Burk
Nov 8, 2012·Virology Journal·André L P AbreuMarcia E L Consolaro
Jan 25, 2013·Journal of Lower Genital Tract Disease·Suzanne E BelinsonJerome L Belinson
Feb 2, 2013·British Journal of Cancer·J CuzickA Szarewski
Mar 27, 2013·Journal of Lower Genital Tract Disease·L Stewart MassadUNKNOWN 2012 ASCCP Consensus Guidelines Conference
Jul 11, 2013·Pharmacogenomics·Jamie Burn
Jul 24, 2013·Cancer Prevention Research·Fang-Hui ZhaoPhilip E Castle
Aug 7, 2013·Journal of Medical Virology·Ana OliveiraÂngela Pista
Aug 24, 2013·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Elizabeth Louise DicksonLevi S Downs
Dec 12, 2013·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Ashrafun NessaElisabeth Andrea Wikström Shemer
Feb 22, 2014·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Jose JeronimoUNKNOWN START-UP Study Group
Apr 11, 2014·Journal of Clinical Microbiology·Mark H EinsteinPhilip E Castle
Nov 6, 2014·PloS One·Zachary Austin CrannellRebecca Richards-Kortum

❮ Previous
Next ❯

Citations

Feb 6, 2020·Biomedical Optics Express·Yubo TangRebecca R Richards-Kortum
May 1, 2021·JCO Global Oncology·Marie-Aimee MuhimpunduAgnes Binagwaho
Jul 9, 2021·ACS Central Science·Marjon ZamaniCatherine M Klapperich
Jun 14, 2021·Clinical Obstetrics and Gynecology·Emma R Allanson, Kathleen M Schmeler
Sep 24, 2021·Expert Review of Proteomics·Coşkun GüzelRainer Bischoff

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC
Laurie ElitMarrette Lee
International Perspectives on Sexual and Reproductive Health
Jacqueline SherrisMark A Barone
© 2021 Meta ULC. All rights reserved